NuvOx Completes Construction of Expanded Manufacturing FacilityNuvOx PharmaApr 30, 20211 min readA new GMP production facility including an ISO 5 cleanroom has been constructed and has initiated operations. Click here to read more...
NuvOx Announces Receipt of IND for Study of NanO2 as Cardioprotectant in Acute Myocardial InfarctionNuvOx Announces Receipt of IND for Study of NanO2 as Cardioprotectant in Acute Myocardial Infarction Tucson, AZ – March 4, 2025 - NuvOx...
NuvOx Announces MHRA Approval to Commence Phase IIb Stroke TrialTucson, AZ – January 21,2025 - NuvOx Therapeutics, Inc. (“NuvOx”) announced that The Medicines and Healthcare products Regulatory Agency...
NuvOx Announces Two New PublicationsNuvOx Announces Two New Publications Tucson, AZ – October 21, 2024 - Co-Founders, Dr. Evan Unger and Dr. Jennifer LH Johnson combine...
Comments